Throat Cancer Market Detailed Summary, Present Industry Size and Future Growth Prospects to 2027
The surge in throat cancer types is leading to the development of the market. Reports that review the pharmaceutical industry have been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities. The market is expected to advance with an increased CAGR in the forecast period.
The factors such as shifting lifestyle trends, elevated number of tobacco customers and growing smoking population is pushing the growth of the throat cancer market globally. Furthermore, the creation of more robust and emerging new drugs is expected to further the development of the market for throat cancer. Also, the raised occurrence of HPV infections is projected to spur the development of the throat cancer market.
Competitive Analysis
Leading players in the global throat cancer market include Amgen Inc., Celgene Corporation, Engeneic Ltd., Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis, F. Hoffman-La Roche AG, Eli Lilly and Company, and Bristol-Myers Squibb.
In April 2019, British researchers in Guy’s & St. Thomas’ NHS Trust in London came up with a new way to get rid of throat cancers using a robotic apparatus. The new robotic apparatus allows for smooth and precise removal of throat cancers. The measure comes in the face of rising evidence that throat cancer is becoming a considerable health threat in the UK: throat cancer has become as common in people in their 50s as it is among people in their 80s, and the prevalence of head and neck cancers has risen by 31% in the last 25 years. Measures such as this are likely to become increasingly popular over the forecast period.
Market Segmentation
The basis on which the throat cancer market is segmented on include types of throat cancer and treatment type.
- The throat cancer market, with respect to type, is divided into pharyngeal cancer and laryngeal cancer.
- The classification of the throat cancer market, according to the treatment type, are surgery, radiation therapy, chemotherapy, and others. Chemotherapy will be holding the largest share in the upcoming years due to its treatment technique, which is combined with radiation therapy for reducing the tumor size and killing the smaller areas of cancer.
Growth Drivers and Key Restraints
Throat cancer can be described as the cancer of vocal cords, larynx, and other locations in the throat. The symptoms include a change in voice, cough, ear pain, sore throat, and issues in swallowing. Throat cancer comprises pharyngeal cancer and laryngeal cancer. Globally, in 2012, close to 157,000 cases of laryngeal cancer were diagnosed. In addition, the National Cancer Institute says that almost 1.1% of the adult population, at some point during their lifetime, is expected to be diagnosed with pharyngeal cancer and 0.4% with laryngeal cancer.
The primary causes of throat cancer include heavy alcohol consumption, smoking tobacco, chewing betel liquid, and HPV infection. The American cancer society suggests that in 2016, roughly 13,430 new cases were diagnosed with laryngeal cancer, affecting 79% of men and 21% of women.
With the surge in the smoking population in emerging countries and the expansion of the aging population, the market is presumed to have a profitable run during the review period. But, the lack of targeted drugs for treating throat cancer could debilitate the growth rate of the market in the subsequent years.
Regional Analysis
The regional review of the throat cancer market includes regions such as Asia Pacific, the America, Europe, Africa and the Middle East. The North American region controls the throat cancer market with the U.S. controlling the prime market share.
The factors that are driving the throat cancer market are the expanding aging population, increasing demand for advanced cancer therapies, escalating government backing in the healthcare sector, and the development of cancer care amenities in budding countries. In the European region, the incidence of throat cancer cases is rising because of the boost in tobacco consumption, smoking, and alcohol consumption in these regions.
The Asia Pacific region is anticipated to develop speedily with increasing countries such as China and India heading this market owing to the swiftly rising healthcare sector and large unmet requirements over the forecast period. The Middle East & African region market mainly, the African region is projected to observe reduced growth due to the deficit of knowledge in medical sector, and reduced development in the medical facilities in Middle East & African region will have restricted development in the market.
